Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neutralization Profile after Recovery from SARS-CoV-2 Omicron Infection
Annika Rössler, Ludwig Knabl, Dorotheé von Laer, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 18, pp. 1764-1766
Open Access | Times Cited: 88

Showing 1-25 of 88 citing articles:

Immune boosting by B.1.1.529 ( Omicron) depends on previous SARS-CoV-2 exposure
Catherine J. Reynolds, Corinna Pade, Joseph M. Gibbons, et al.
Science (2022) Vol. 377, Iss. 6603
Open Access | Times Cited: 314
Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5
Izumi Kimura, Daichi Yamasoba, Tomokazu Tamura, et al.
Cell (2022) Vol. 185, Iss. 21, pp. 3992-4007.e16
Open Access | Times Cited: 238
Imprinted antibody responses against SARS-CoV-2 Omicron sublineages
Young‐Jun Park, Dora Pinto, Alexandra C. Walls, et al.
Science (2022) Vol. 378, Iss. 6620, pp. 619-627
Open Access | Times Cited: 193
Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines
John E. Bowen, Amin Addetia, Ha V. Dang, et al.
Science (2022) Vol. 377, Iss. 6608, pp. 890-894
Open Access | Times Cited: 174
COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection
Wei-Yu Chi, Yen-Der Li, Hsin‐Che Huang, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 166
SARS-CoV-2 Omicron Variant: Epidemiological Features, Biological Characteristics, and Clinical Significance
Yifei Guo, Jiajia Han, Yao Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 101
Impact of antigenic evolution and original antigenic sin on SARS-CoV-2 immunity
Muriel Aguilar-Bretones, Ron A. M. Fouchier, Marion Koopmans, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 1
Open Access | Times Cited: 81
BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants
Annika Rössler, Antonia Netzl, Ludwig Knabl, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 73
Immunological imprinting: Understanding COVID-19
Marios Koutsakos, Ali H. Ellebedy
Immunity (2023) Vol. 56, Iss. 5, pp. 909-913
Open Access | Times Cited: 59
Clinical Characteristics of COVID-19 Patients Infected by the Omicron Variant of SARS-CoV-2
Jianguo Zhang, Nan Chen, Daguo Zhao, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 61
Heterogeneous Infectivity and Pathogenesis of SARS-CoV-2 Variants Beta, Delta and Omicron in Transgenic K18-hACE2 and Wildtype Mice
Ferran Tarrés-Freixas, Benjamin Trinité, Anna Pons-Grífols, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 57
SARS-CoV-2 variants – Evolution, spike protein, and vaccines
Kai-Wei K. Chen, Daniel Tsung‐Ning Huang, Li‐Min Huang
Biomedical Journal (2022) Vol. 45, Iss. 4, pp. 573-579
Open Access | Times Cited: 49
Different Neutralization Profiles After Primary SARS-CoV-2 Omicron BA.1 and BA.2 Infections
Iris Medits, David Niklas Springer, Marianne Graninger, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 40
Imprinted antibody responses against SARS-CoV-2 Omicron sublineages
Young‐Jun Park, Dora Pinto, Alexandra C. Walls, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 37
Rapidly shifting immunologic landscape and severity of SARS-CoV-2 in the Omicron era in South Africa
Kaiyuan Sun, Stefano Tempia, Jackie Kleynhans, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 35
Hybrid Immunity to SARS-CoV-2 from Infection and Vaccination—Evidence Synthesis and Implications for New COVID-19 Vaccines
Júlia Spinardi, Amit Srivastava
Biomedicines (2023) Vol. 11, Iss. 2, pp. 370-370
Open Access | Times Cited: 32
Characterizing SARS-CoV-2 neutralization profiles after bivalent boosting using antigenic cartography
Annika Rössler, Antonia Netzl, Ludwig Knabl, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 31
Heterologous ChAdOx1/BNT162b2 vaccination induces stronger immune response than homologous ChAdOx1 vaccination: The pragmatic, multi-center, three-arm, partially randomized HEVACC trial
Zoltán Bánki, José Mateus, Annika Rössler, et al.
EBioMedicine (2022) Vol. 80, pp. 104073-104073
Open Access | Times Cited: 36
Prior Vaccination Exceeds Prior Infection in Eliciting Innate and Humoral Immune Responses in Omicron Infected Outpatients
Hye‐Kyung Lee, Ludwig Knabl, Mary Walter, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 30
Reduced Sensitivity of Commercial Spike-Specific Antibody Assays after Primary Infection with the SARS-CoV-2 Omicron Variant
David Niklas Springer, Thomas Perkmann, Claudia Jani, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 5
Open Access | Times Cited: 30
Distinctive serotypes of SARS-related coronaviruses defined by convalescent sera from unvaccinated individuals
Chee Wah Tan, Feng Zhu, Wan Ni Chia, et al.
hLife (2023) Vol. 1, Iss. 1, pp. 26-34
Open Access | Times Cited: 18
Efficacy of an unmodified bivalent mRNA vaccine against SARS-CoV-2 variants in female small animal models
Björn Corleis, Donata Hoffmann, Susanne Rauch, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 17
Neutralizing antibodies to Omicron after the fourth SARS-CoV-2 mRNA vaccine dose in immunocompromised patients highlight the need of additional boosters
María Rescigno, Chiara Agrati, Carlo Salvarani, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Antibody and B Cell Responses to SARS-CoV-2 Infection and Vaccination: The End of the Beginning
Katharina Röltgen, Scott D. Boyd
Annual Review of Pathology Mechanisms of Disease (2023) Vol. 19, Iss. 1, pp. 69-97
Open Access | Times Cited: 15
Nonhuman primate antigenic cartography of SARS-CoV-2
Annika Rössler, Antonia Netzl, Ninaad Lasrado, et al.
Cell Reports (2025) Vol. 44, Iss. 1, pp. 115140-115140
Open Access
Page 1 - Next Page

Scroll to top